UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $106,000 | -48.8% | 5,668 | +23.4% | 0.02% | -54.0% |
| Q2 2020 | $207,000 | -5.0% | 4,594 | 0.0% | 0.05% | -32.4% |
| Q1 2020 | $218,000 | -33.7% | 4,594 | 0.0% | 0.07% | +2.8% |
| Q4 2019 | $329,000 | -8.4% | 4,594 | 0.0% | 0.07% | -6.5% |
| Q2 2019 | $359,000 | +31.0% | 4,594 | 0.0% | 0.08% | +28.3% |
| Q1 2019 | $274,000 | +35.6% | 4,594 | -17.2% | 0.06% | +30.4% |
| Q3 2018 | $202,000 | -3.3% | 5,549 | +0.2% | 0.05% | -23.3% |
| Q2 2018 | $209,000 | – | 5,538 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |